These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2363412

  • 1. Bone marrow in vitro growth and cytogenetic studies in patients with FAB-classified primary myelodysplastic syndromes.
    Swolin B, Rödjer S, Westin J.
    Am J Hematol; 1990 Jul; 34(3):175-80. PubMed ID: 2363412
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneous colony forming ability in vitro of the abnormal clone-derived granulocyte-macrophage precursors in myelodysplastic syndromes.
    Okuda T, Yokota S, Maekawa T, Sonoda Y, Misawa S, Takino T, Abe T.
    Leuk Res; 1988 Jul; 12(8):687-92. PubMed ID: 3184986
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
    Shih LY, Chiu WF, Lee CT.
    Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958
    [Abstract] [Full Text] [Related]

  • 4. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
    Dan K, An E, Futaki M, Inokuchi K, Gomi S, Yamada T, Ogata K, Tanabe Y, Ohki I, Shinohara T.
    Acta Haematol; 1993 Dec; 89(3):113-8. PubMed ID: 8362599
    [Abstract] [Full Text] [Related]

  • 5. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
    Zhang F, Hao Y, Pang W.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
    [Abstract] [Full Text] [Related]

  • 6. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.
    Geissler K, Hinterberger W, Jäger U, Bettelheim P, Neumann E, Haas O, Ambros P, Chott A, Radaszkiewicz T, Lechner K.
    Blut; 1988 Jul; 57(1):45-9. PubMed ID: 3390617
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Analysis of in vitro characteristics of colony-forming cells in myelodysplastic syndrome and comparison with that in non-severe aplastic anemia].
    Zhang TJ, Feng M, Zheng YZ, Li XX, Xu ZF, Qin TJ, Zhang Y, Yang YB, Liu JX, Ren YS, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):516-21. PubMed ID: 22967409
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA, Parovichnikova EN, Kokhno AV, Domracheva EV, Manakova TE, Mal'tseva IuS, Konnova ML, Shishigina LA, Savchenko VG.
    Ter Arkh; 2013 Jul; 85(7):34-42. PubMed ID: 24137945
    [Abstract] [Full Text] [Related]

  • 12. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
    Lewis S, Oscier D, Boultwood J, Ross F, Fitchett M, Rack K, Abrahamson G, Buckle V, Wainscoat JS.
    Am J Hematol; 1995 Jul; 49(3):194-200. PubMed ID: 7604812
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R.
    Li B, Liu J, Qu S, Gale RP, Song Z, Xing R, Liu J, Ren Y, Xu Z, Qin T, Zhang Y, Fang L, Zhang H, Pan L, Hu N, Cai W, Zhang P, Huang G, Xiao Z.
    Oncotarget; 2016 Oct 18; 7(42):68023-68032. PubMed ID: 27655727
    [Abstract] [Full Text] [Related]

  • 15. Prognostic implication of sequential bone marrow cultures in the myelodysplastic syndromes.
    Yoshida Y, Yoshida C, Tohyama K, Ohmori S, Ohmori M, Ueda Y, Taniguchi Y, Uchino H.
    Leuk Res; 1989 Oct 18; 13(11):967-72. PubMed ID: 2607778
    [Abstract] [Full Text] [Related]

  • 16. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G, Tosi P, Finelli C, Gamberi B, Zauli G, Cenacchi A, Fogli M, Colombini R, Tura S.
    Haematologica; 1992 Oct 18; 77(2):142-5. PubMed ID: 1383105
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MDS-macrophage derived inhibitory activity on myelopoiesis of MDS abnormal clones.
    Ohmori S, Ohmori M, Yamagishi M, Okuma M.
    Br J Haematol; 1993 Mar 18; 83(3):388-91. PubMed ID: 8485044
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.